Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jan 20, 2022 PRIMARY DOCUMENT
8-K Jan 19, 2022 8-K
4 Jan 12, 2022 PRIMARY DOCUMENT
4 Jan 7, 2022 FORM 4 SUBMISSION
4 Jan 7, 2022 FORM 4 SUBMISSION
4 Jan 7, 2022 FORM 4 SUBMISSION
8-K Jan 4, 2022 8-K
4 Jan 3, 2022 PRIMARY DOCUMENT
4 Dec 29, 2021 FORM 4 SUBMISSION
CT ORDER Dec 16, 2021
4 Nov 12, 2021 FORM 4 SUBMISSION
8-K Nov 10, 2021 8-K
10-Q Nov 10, 2021 10-Q
4 Nov 2, 2021 PRIMARY DOCUMENT
8-K Oct 28, 2021 8-K
3 Oct 14, 2021 FORM 3 SUBMISSION
8-K Oct 12, 2021 8-K
4 Oct 4, 2021 PRIMARY DOCUMENT
8-K Sep 30, 2021 8-K
S-8 Sep 20, 2021 S-8
SC 13D/A Sep 16, 2021 AMENDMENT TO FORM SC 13D
4 Sep 15, 2021 PRIMARY DOCUMENT
4 Sep 10, 2021 PRIMARY DOCUMENT
4 Sep 1, 2021 PRIMARY DOCUMENT
4 Aug 30, 2021 FORM 4 SUBMISSION
← Newer Page 10 of 21 · 513 filings Older →